Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05032573 · ClinicalTrials.gov registry record · NA
Feasibility of Olive Oil for Reducing Facial Pain of Trigeminal Neuralgia
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT05032573: Completed NA study, sponsored by University of Florida.
NCT05032573 is a NA study that has completed, run by University of Florida. The registered enrollment target is 52 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05032573, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
This is a 16-week non-blinded, parallel, controlled trial to determine the feasibility and potential efficacy of an olive oil dietary intervention to alleviate facial pain caused by trigeminal neuralgia type 1 (TGN).
Primary Outcome
Daily olive oil intake in tablespoons per day.
Interventions
- DIETARY_SUPPLEMENT Olive oil and Dietary Guideline recommendations
- OTHER Dietary Guideline recommendations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2021-10-05 |
| Est. Completion | 2023-03-31 |
| Phase | NA |
What the finished NCT05032573 record still lists
NCT05032573 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Olive oil and Dietary Guideline recommendations is the first listed.
NCT05032573 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05032573 about?
NCT05032573 is a clinical study titled "Feasibility of Olive Oil for Reducing Facial Pain of Trigeminal Neuralgia". This is a 16-week non-blinded, parallel, controlled trial to determine the feasibility and potential efficacy of an olive oil dietary intervention to alleviate facial pain caused by trigeminal neuralgia type 1 (TGN).
What is the current status of trial NCT05032573?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2021-10-05. Estimated completion is 2023-03-31.
What interventions are being tested in trial NCT05032573?
The interventions under investigation include: Olive oil and Dietary Guideline recommendations (DIETARY_SUPPLEMENT), Dietary Guideline recommendations (OTHER).
Who is sponsoring clinical trial NCT05032573?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05032573's enrollment target sits among peer trials
52 1272nd of 2000 higher than 722 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI